OCATA THERAPEUTICS, INC.
Biotech · Acquired
Human pluripotent stem cell-derived photoreceptor progenitor cells for retinal transplantation
ocata.com →- Grants
- $442K
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 13
- 5 granted · 8 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152016
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Human embryonic stem cell-derived mesenchymal stromal cell therapy for lupus nephritis | $225,639 | |
| Federal grant | Department of Health and Human Services · Phase I · Retinitis pigmentosa therapy with human embryonic stem cell- and induced pluripotent stem cell-derived photoreceptor progenitors | $216,072 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1890 | Antlia Bioscience, Inc. | — | $6.9M |
| 1891 | PLEOPHARMA, INC. | — | $17M |
| 1892 | D2G ONCOLOGY, INC. | — | $6.6M |
| 1893 | OCATA THERAPEUTICS, INC. | — | — |
| 1894 | CELLECTAR, Inc. | — | $2.7M |
| 1895 | SUNNYLIFE PHARMA INC. | — | — |
| 1896 | NASH HOLDINGS, LLC | — | $1.4M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Modalities For The Treatment Of Degenerative Diseases Of The Retinagranted
- Photoreceptors And Photoreceptor Progenitors Produced From Pluripotent Stem Cellsapplication
- Photoreceptors And Photoreceptor Progenitors Produced From Pluripotent Stem Cellsapplication
- Modalities For The Treatment Of Degenerative Diseases Of The Retinagranted
- Modalities For The Treatment Of Degenerative Diseases Of The Retinagranted
- Methods For Producing Pluripotent Stem Cell-generated Embryos, And Animals Derived Therefromapplication
- Modalities for the treatment of degenerative diseases of the retinagranted
- Modalities For The Treatment Of Degenerative Diseases Of The Retinagranted
- Assays For Potency Of Human Rpe Cells And Photoreceptor Progenitorsapplication
- Clinical Formulationsapplication
- Clinical Formulationsapplication
- Photoreceptors And Photoreceptor Progenitors Produced From Pluripotent Stem Cellsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.